Resistance to HIV Infection
NCT00069485 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2007-09-18
Summary
The immune systems of some individuals may be capable of resisting HIV infection. These individuals do not appear to be infected with HIV despite multiple sexual encounters with HIV infected partners. This study will examine the immune systems of these individuals to determine what factors are responsible for their ability to resist HIV infection.
Study hypothesis: Some long-term, multiply-exposed seronegative persons have relative resistance to HIV infection maintained by T cell responses.
Conditions
- HIV Infections
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Julie McElrath, MD, PhD · University of Washington
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1995-12-31
Countries
- United States
Study Locations
More Related Trials
-
Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
NCT00662194 ·Status: UNKNOWN
-
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
NCT00000632 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HIV in Newly Infected Individuals
NCT00000930 ·Status: COMPLETED
-
Serological Responses to Adjuvanted Versus Non-adjuvanted Influenza Vaccines Among People With HIV: a Randomized Clinical Trial
NCT07126652 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
NCT00859677 ·Status: COMPLETED
-
Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
NCT00006495 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
NCT01386489 ·Status: COMPLETED ·Phase: PHASE1
-
Selection of a Protective T Cell-based HIV-1/FIV Vaccine
NCT02389595 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
NCT01381029 ·Status: COMPLETED
-
Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
NCT00238459 ·Status: COMPLETED
-
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
NCT00000756 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
NCT00058734 ·Status: COMPLETED ·Phase: PHASE1
-
Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity
NCT02886416 ·Status: COMPLETED
-
Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
NCT01054872 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
NCT00000779 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals
NCT03225118 ·Status: COMPLETED
-
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
NCT00006444 ·Status: COMPLETED
-
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
NCT00002359 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
NCT01376726 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication
NCT00006578 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination
NCT00006153 ·Status: TERMINATED ·Phase: PHASE1
-
Antigenic Competition in HIV Preventive Vaccines
NCT01159990 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
NCT00125099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination
NCT00005758 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441 ·Status: COMPLETED ·Phase: PHASE3